These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23839239)

  • 21. Efficient production and purification of extracellular domain of human FGFR-Fc fusion proteins from Chinese hamster ovary cells.
    Sokolowska-Wedzina A; Borek A; Chudzian J; Jakimowicz P; Zakrzewska M; Otlewski J
    Protein Expr Purif; 2014 Jul; 99():50-7. PubMed ID: 24727156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fc specific IgG glycosylation profiling by robust nano-reverse phase HPLC-MS using a sheath-flow ESI sprayer interface.
    Selman MH; Derks RJ; Bondt A; Palmblad M; Schoenmaker B; Koeleman CA; van de Geijn FE; Dolhain RJ; Deelder AM; Wuhrer M
    J Proteomics; 2012 Feb; 75(4):1318-29. PubMed ID: 22120122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the correlation between charge and glycosylation of IgG1 variants by liquid chromatography-mass spectrometry.
    Yang JM; Ai J; Bao Y; Yuan Z; Qin Y; Xie YW; Tao D; Fu D; Peng Y
    Anal Biochem; 2014 Mar; 448():82-91. PubMed ID: 24287081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical comparability assessment on glycosylation of ziv-aflibercept and the biosimilar candidate.
    Shen Z; Wang Y; Xu H; Zhang Q; Sha C; Sun B; Li Q
    Int J Biol Macromol; 2021 Jun; 180():494-509. PubMed ID: 33684428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of the Fc fusion format to generate tag-free bi-specific diabodies.
    Asano R; Ikoma K; Kawaguchi H; Ishiyama Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
    FEBS J; 2010 Jan; 277(2):477-87. PubMed ID: 20015073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC-MS readout.
    Falck D; Wuhrer M
    Nat Protoc; 2024 Jun; 19(6):1887-1909. PubMed ID: 38383719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE.
    Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G
    Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of intact glycopeptides reveals the impact of culture media on site-specific glycosylation of EPO-Fc fusion protein generated by CHO-GS cells.
    Wang Q; Yang G; Wang T; Yang W; Betenbaugh MJ; Zhang H
    Biotechnol Bioeng; 2019 Sep; 116(9):2303-2315. PubMed ID: 31062865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precise O-Glycosylation Site Localization of CD24Fc by LC-MS Workflows.
    Li X; Wilmanowski R; Gao X; VanAernum ZL; Donnelly DP; Kochert B; Schuessler HA; Richardson D
    Anal Chem; 2022 Jun; 94(23):8416-8425. PubMed ID: 35622908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elimination of N-glycosylation by site mutation further prolongs the half-life of IFN-α/Fc fusion proteins expressed in Pichia pastoris.
    Jia H; Guo Y; Song X; Shao C; Wu J; Ma J; Shi M; Miao Y; Li R; Wang D; Tian Z; Xiao W
    Microb Cell Fact; 2016 Dec; 15(1):209. PubMed ID: 27927205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
    Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
    Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site-specific N-glycosylation of chicken serum IgG.
    Suzuki N; Lee YC
    Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of capillary electrophoresis, liquid chromatography, electrospray-mass spectrometry and matrix-assisted laser desorption/ionization - time of flight - mass spectrometry to the characterization of recombinant human erythropoietin.
    Zhou GH; Luo GA; Zhou Y; Zhou KY; Zhang XD; Huang LQ
    Electrophoresis; 1998 Oct; 19(13):2348-55. PubMed ID: 9788319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlative N-glycan and charge variant analysis of cetuximab expressed in murine, chinese hamster and human expression systems.
    Trappe A; Füssl F; Millán-Martín S; Ronan R; Zaborowska I; Bones J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Apr; 1194():123186. PubMed ID: 35240429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of LC and LC/MS methods for quantifying N-glycosylation in recombinant IgGs.
    Sinha S; Pipes G; Topp EM; Bondarenko PV; Treuheit MJ; Gadgil HS
    J Am Soc Mass Spectrom; 2008 Nov; 19(11):1643-54. PubMed ID: 18707900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
    Hodoniczky J; Zheng YZ; James DC
    Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry.
    Chevreux G; Tilly N; Bihoreau N
    Anal Biochem; 2011 Aug; 415(2):212-4. PubMed ID: 21596014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-depth site-specific O-Glycosylation analysis of therapeutic Fc-fusion protein by electron-transfer/higher-energy collisional dissociation mass spectrometry.
    Hashii N; Suzuki J; Hanamatsu H; Furukawa JI; Ishii-Watabe A
    Biologicals; 2019 Mar; 58():35-43. PubMed ID: 30704904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and Quantification of an Fc-FGF21 Fusion Protein in Rat Serum Using Immunoaffinity LC-MS.
    Li F; Weng Y; Zhang G; Han X; Li D; Neubert H
    AAPS J; 2019 Jul; 21(5):84. PubMed ID: 31286285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Proteolytic Cleavage of Therapeutic Monoclonal Antibody Hinge Region: More Than a Matter of Subclass.
    Deveuve Q; Lajoie L; Barrault B; Thibault G
    Front Immunol; 2020; 11():168. PubMed ID: 32117299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.